Clinical trial NCT00896935: Arizona Cancer Center Biospecimen Repository
Official title: Arizona Cancer Center Biospecimen Repository
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Cancer
Keywords: cancer
Lead sponsor: University of Arizona
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2009-05-12
Enrollment: 10000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.

Brief summary: RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Detailed description: OBJECTIVES:

* Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.
* Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.
* Provide quality-controlled storage and management of the specimen bank.
* Collect relevant clinical and pathologic information with appropriate privacy protection.
* Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Eligibility criteria: DISEASE CHARACTERISTICS:

* Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

* NA

PRIOR CONCURRENT THERAPY:

* NA

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Primary outcomes:
measure: Provision of tissue samples and biospecimens for translational study
timeFrame: July 2024
Secondary outcomes:
Other outcomes:
Locations:
city: Tucson
country: United States
facility: Arizona Cancer Center at University of Arizona Health Sciences Center
state: Arizona
Study officials:
affiliation: University of Arizona
name: Setsuko K. Chambers, MD
role: PRINCIPAL_INVESTIGATOR
References: